BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging & Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251030T080000
DTEND;TZID=Europe/Vienna:20271130T170000
DTSTAMP:20260407T113318
CREATED:20240228T100725Z
LAST-MODIFIED:20251118T083202Z
UID:1520-1761811200-1827594000@esmit.eanm.org
SUMMARY:Bringing Alpha Therapies into Clinical Practice
DESCRIPTION:UEMS EACCME has granted the accreditation of 3 CME credits for this event. \n\n\n\n \n\n\n\n \n\n\n\nThis online course offers a comprehensive introduction to alpha therapy in nuclear medicine\, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences\, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting radioisotopes to deliver lethal doses of radiation directly to cancer cells while sparing healthy tissues. It is highly efficient and lately increasingly explored for scientific purposes in the oncologic domain . With this course we aim at bringing Alpha Therapies into clinical practice through various\, relevant presentations. A panel of experts and EANM members will update you on the type of alpha-emitting radioisotopes available\, describing all important steps required for production and radiopharmaceutical development. The advantages\, but also the challenges related to the use of Alpha therapy will amply be discussed and supported by clinical examples. You will be initiated in the existing and ongoing therapeutic trials\, with the best yet to come. Dosimetry will play a pivotal role in this course\, underlying its role in clinical practice. Finally\, The Alphamet project will be presented\, allowing you to get updated with the latest insights from Theranostics. \n\n\n\n \n\n\n\nRPH \n\n\n\nTargeted Alpha Therapy (TAT) represents a cutting-edge advancement in cancer treatment\, harnessing the potent\, cell-killing power of alpha particles to precisely destroy malignant cells while minimizing damage to surrounding healthy tissue. This part of the course course explores the transformative potential of TAT\, highlighting its exceptional potency\, unique ability to overcome radio-resistance\, and its role in modern theranostics. You’ll gain insight into the selection of optimal alpha-emitting radionuclides\, the biological advantages of short-range high-energy emissions\, and the complex challenges involved in the development\, production\, and clinical translation of these innovative therapies. Join us to deepen your knowledge and be part of the future of targeted radiopharmaceuticals in oncology. \n\n\n\nOncology \n\n\n\n \n\n\n\nIn this part of the course\, participants will explore the main advantages of alpha-emitting radionuclides in oncology\, while also gaining an understanding of the clinical challenges associated with their use. You will become familiar with the key clinical aspects of Alpha-Therapy\, supported by real-world perspectives and case insights. The course also highlights current and upcoming therapeutic trials\, providing valuable knowledge on the future direction of this rapidly evolving field. \n\n\n\nDosimetry \n\n\n\nParticipants will begin by exploring the basic concepts of dosimetry with alpha emitters\, highlighting key differences from beta emitter dosimetry. The course then delves into the clinical relevance of alpha dosimetry\, demonstrating how accurate dose assessments can inform and optimize the management of patients undergoing treatment with alpha radiotherapeutics. In addition\, the course presents the Alphamet project\, a major European initiative that addresses the specific metrological challenges associated with targeted alpha therapies. By examining the goals and contributions of Alphamet\, learners will gain insight into how this research supports the safe and effective integration of alpha therapy into routine clinical practice. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo gain an overview of the main advantages of Alpha-radionuclides\n\n\n\nTo learn about the challenges of alpha emitters\, complex production; transport issues\, waste management and handling\n\n\n\nTo get insights on radiobiology: radiotoxicity & effectiveness\n\n\n\nTo have a comprehensive review of research candidates\n\n\n\nTo provide an overview of the main advantages when using Alpha-Therapy in clinical practice\n\n\n\nTo learn about the clinical challenges when using Alpha-Therapy\n\n\n\nTo get insights into current and future trials focusing on Alpha-Therapy\n\n\n\nTo learn the most basic aspects about dosimetry of alpha emitters showing the main differences with dosimetry of beta emitters\n\n\n\nTo learn how dosimetry results could be used in the management of patients treated with radiopharmaceuticals that include alpha emitters\n\n\n\nTo learn on the Alphamet project\, which addresses the unique and unmet metrological challenges of targeted alpha therapies\, contributing to their safe and optimised implementation into routine clinical practice\n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear medicine physicians\, radiologists\, medical oncologists\, urologists\, radiation oncologists\, medical physicists\, biologists\, researchers\n\n\n\nRadiochemists\, radiopharmacists\, physicists\, medical physicists\, biologists\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeClick to see the full event programme. View the Programme\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n\n\nDana NiculaeSpeaker \n\n\n\n\n\nEmma AnaheimSpeaker \n\n\n\n\n\nJanke KleyhansSpeaker \n\n\n\n\n\nMarianna TosatoSpeaker \n\n\n\n\n\nWolfgang FendlerSpeaker \n\n\n\n\n\nMathias ZacherlSpeaker \n\n\n\n\n\n\n\nPablo Mínguez GabiñaSpeaker \n\n\n\n\n\nMike SathekgeSpeaker \n\n\n\n\n\nDaniela Oprea-LagerSpeaker \n\n\n\n\n\nAna Denis-BacelarSpeaker \n\n\n\n\n\nJoe O’SullivanSpeaker \n\n\n\n\n\n\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once enrolled\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/bringing-alpha-therapies-into-clinical-practice-2/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Online Course,Radiopharmaceuticals,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251103T000000
DTEND;TZID=Europe/Vienna:20271130T235959
DTSTAMP:20260407T113318
CREATED:20251030T092126Z
LAST-MODIFIED:20260309T102411Z
UID:3146-1762128000-1827619199@esmit.eanm.org
SUMMARY:NucMed Essentials - MSK Basics
DESCRIPTION:UEMS EACCME has granted the accreditation of 5 CME credits for this event. \n\n\n\n \n\n\n\n \n\n\n\nNew ESMIT Learning format: Self-paced online course followed by a live session with the course faculty\, where participants are able to ask their questions live!* \n\n\n\n \n\n\n\n \n\n\n\nNuclear Medicine Essentials: The Basics of MSK provides a comprehensive introduction to musculoskeletal applications in nuclear medicine\, focusing on both diagnostic and therapeutic techniques. Participants will explore the fundamental principles of bone scintigraphy\, including its physiological basis\, imaging protocols\, and wide range of clinical applications\, with emphasis on its continued importance in patient care. The course also delves into advanced imaging through NaF PET\, highlighting its uptake mechanisms\, technical considerations\, and growing role in oncology and other clinical contexts. Building on these diagnostic foundations\, the course transitions into therapeutic strategies\, such as the use of Radium-223 in the treatment of bone metastases\, with attention to efficacy\, safety\, and radioprotection measures. \n\n\n\nBeyond theoretical understanding\, the program emphasizes practical application and clinical relevance. Learners will gain exposure to cutting-edge research\, evidence-based workflows\, and therapeutic innovations in the field. Radiosynovectomy for arthritis treatment is presented as an important example of nuclear medicine’s therapeutic scope\, with procedural insights and expected outcomes supported by real-world case demonstrations. Departmental video presentations supplement each topic\, offering participants a unique opportunity to see workflows and protocols in practice. By the end of the course\, attendees will not only understand the fundamentals of musculoskeletal nuclear medicine but also appreciate its evolving role in modern imaging and therapy.  \n\n\n\n \n\n\n\n \n\n\n\n*The live follow-up session will only be held if there is interest – please submit your questions at the dedicated space on our eLearning platform. The date of the live session will be announced in due time. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nI. Understand the fundamentals of bone scan techniques: \n\n\n\n \n\n\n\n\nDescribe the theoretical considerations and acquisition protocols for bone scans.\n\n\n\nExplain the clinical applications of bone scans across various pathologies.\n\n\n\n\nII. Gain insights into NaF PET for bone imaging: \n\n\n\n\nSummarize the theoretical considerations and acquisition protocols specific to NaF PET.\n\n\n\nRecognize the essential applications of NaF PET in oncology and other clinical cases.\n\n\n\n\nIII. Explore therapeutic approaches for bone metastases using bone-seeking agents: \n\n\n\n\nReview current theoretical knowledge and recent publications on the treatment of bone metastases.\n\n\n\nIdentify practical considerations and procedural steps involved in bone-seeking agent therapies.\n\n\n\n\nIV. Learn the application of radiosynovectomy in managing arthritis: \n\n\n\n\nDescribe the indications\, procedures\, and expected outcomes of radiosynovectomy for arthritis treatment.\n\n\n\n\n \n\n\n\n \n\n\n\nV. Apply knowledge through visual and practical insights from real-world clinical settings: \n\n\n\n\nAssess clinical workflows and procedural nuances via department video presentations for each session.\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nTechnologists\, nuclear medicine physicians and residents \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nKnut LiepeSpeaker \n\n\n\n\n\nJules Zhang-YinSpeaker \n\n\n\n\n\nPaolo TurcoSpeaker
URL:https://esmit.eanm.org/event/nucmed-essentials-msk-basics/
CATEGORIES:NucMed Essentials
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251107T133000
DTEND;TZID=Europe/Vienna:20251107T143000
DTSTAMP:20260407T113319
CREATED:20241017T081503Z
LAST-MODIFIED:20251104T110112Z
UID:1940-1762522200-1762525800@esmit.eanm.org
SUMMARY:Nuclear Medicine-related Highlights from ESMO 2025
DESCRIPTION:This ESMO 2025 webinar will cover a range of topics\, including the latest advancements treatment options\, imaging modalities and performant tracers related to solid and liquid tumors. The focus of this Live event will be the recent advances in solid & liquid tumor treatment\, clinical trials and emerging therapies\, biomarkers in solid tumors and multidisciplinary approaches. The importance of collaboration among medical oncologists\, radiologists\, nuclear medicine physicians\, pathologists and surgeons will be underlined\, based on clinical examples. Challenges and opportunities in immunotherapy for solid tumors will also be addressed\, with special attention for personalized treatment plans in specific cancers\, like lung cancer\, breast cancer\, colorectal and prostate cancer. \n\n\n\nPlease note that the webinar will be recorded\, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform\, under the webinar title. A handout of the presentation materials will also be available on the platform. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nAttendees will get insight into recent advances in solid/ liquid tumor treatment\n\n\n\nAttendees will be familiarized with the latest developments when diagnosing\, staging and treating different types of solid and liquid tumors.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nFellows and Medical Specialists in Nuclear Medicine\, Radiology\, Medical Oncology\, Urology\, Surgery\, Pathology and Radiation Oncology\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nDavid KerstingModerator \n\n\n\n\n\nKarolien GoffinSpeaker \n\n\n\n\n\nMatthias EiberSpeaker \n\n\n\n\n\n\n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/nuclear-medicine-related-highlights-from-esmo-2025/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251114T133000
DTEND;TZID=Europe/Vienna:20251114T143000
DTSTAMP:20260407T113319
CREATED:20241017T081732Z
LAST-MODIFIED:20251112T090155Z
UID:1942-1763127000-1763130600@esmit.eanm.org
SUMMARY:Paediatric Thyroid Cancer
DESCRIPTION:This webinar aims to underly the most relevant differences with the adults DCT regarding epidemiology\, genetics\, pathology\, immunoistopathology\, diagnostic tools and treatment\, especially for RAI theranostic procedure. Additionally\, the webinar will also go over the main GL recommendations\, as well as present and discuss two emblematic or tricky cases. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\n\nThe aim of this course is to sensitise the attendees about the correct way to recognise\, diagnose and treat DTC in children.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\n\nPhysicians\, residents with special interest on endocrinlogy and endo-oncology\, nuclear medicine specialists\, nurses and technicians of nuclear medicine units.\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nSuggested Readings\n\n\n\n \n\n\n\n \n\n\n\n\nFrancis GL\, Waguespack SG\, Bauer AJ\, Angelos P\, Benvenga S\, Cerutti JM\, Dinauer CA\, Hamilton J\, Hay ID\, Luster M\, Parisi MT\, Rachmiel M\, Thompson GB\, Yamashita S; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. PMID: 25900731; PMCID: PMC4854274.\n\n\n\nLebbink CA\, Links TP\, Czarniecka A\, Dias RP\, Elisei R\, Izatt L\, Krude H\, Lorenz K\, Luster M\, Newbold K\, Piccardo A\, Sobrinho-Simões M\, Takano T\, Paul van Trotsenburg AS\, Verburg FA\, van Santen HM. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J. 2022 Nov 29;11(6):e220146. doi: 10.1530/ETJ-22-0146. PMID: 36228315; PMCID: PMC9716393.\n\n\n\nCzarniecka A\, Woźniak G\, Kropińska A\, Jarząb B\, Handkiewicz-Junak D. Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci]. Endokrynol Pol. 2019;70(4):357-366. doi: 10.5603/EP.a2019.0033. PMID: 31489960.\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n\n\nDesiree DeandreisSpeaker \n\n\n\n\n\nCatia OliantiModerator \n\n\n\n\n\nLivia LamartinaSpeaker \n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/paediatric-thyroid-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251120T090000
DTEND;TZID=Europe/Vienna:20251121T123000
DTSTAMP:20260407T113319
CREATED:20241017T084331Z
LAST-MODIFIED:20250929T122752Z
UID:1966-1763629200-1763728200@esmit.eanm.org
SUMMARY:Focus on FDG PET/CT in Inflammatory and Infectious Diseases
DESCRIPTION:Inflammation comes from the Latin word inflammare\, to ignite or to set on fire – we want to ignite your interest in imaging inflammation and infection. \n\n\n\nInflammatory and infectious diseases can be clinically challenging. Many are systemic with highly variable clinical presentations and sometimes vague and non-specific symptoms and findings. Association with implanted material like artificial heart valves\, joint or vascular prostheses may hamper imaging or give rise to non-specific findings. \n\n\n\nAlthough the imaging strategy may still be considered unclarified in some settings\, [18F]FDG-PET/CT is now established as a key modality in the diagnostic workup of several inflammatory and infectious diseases. The course aims to provide the participants with an overview of the evidence and practical use of [18F]FDG-PET/CT in suspected inflammation and infection and covers the most well-established indications.  \n\n\n\nLed by European experts\, the sessions mix short overview lectures with interactive sessions to allow participants to engage in discussions and exchange experiences on daily practices with each other and the faculty. \n\n\n\nRegister nowThe course is fully booked. Please contact us at esmit@eanm.org if you would like to be added to the waiting list! \n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nTo provide general insights into the use of [18F]FDG PET/CT in suspected or manifest inflammation and infection\, e.g. patient preparation and protocols\n\n\n\nTo provide insights into how and when to use [18F]FDG PET/CT in suspected or manifest specific inflammatory diseases\, e.g. vasculitis\, polymyalgia rheumatica\, other reumatologic diseases\, and  sarcoidosis\n\n\n\nTo provide insights into how and when to use [18F]FDG PET/CT in suspected or manifest specific infectious diseases\, e.g. fever and inflammation of unknown origin\, blood stream infections\, osteomyelitis and spondylodiscitis\, cardiac and vascular infections\n\n\n\nTo provide some insights into novel developments with this domain\, e.g. FAPI\, bacteria-specific tracers\, and long axial field of view scanners\n\n\n\nTo facilitate an open discussion on pro and cons of [18F]FDG PET/CT in suspected or manifest inflammation and infections\n\n\n\n\n\n\nTarget Audience\n\n\n\nNuclear medicine specialists with basic experience in reading [18F]FDG-PET/CT in inflammatory and infectious diseases.  \n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSoren HessSpeakerOdense\, Denmark \n\n\n\n\n\nOlivier GheysensSpeakerBrussels\, Belgium \n\n\n\n\n\nAyah NawwarSpeakerBristol\, UK \n\n\n\n\n\nGiorgio TregliaSpeakerLugano\, Switzerland \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/focus-on-fdg-pet-ct-in-inflammatory-and-infectious-diseases/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251201T100000
DTEND;TZID=Europe/Vienna:20251201T110000
DTSTAMP:20260407T113319
CREATED:20250513T093530Z
LAST-MODIFIED:20251118T083337Z
UID:2534-1764583200-1764586800@esmit.eanm.org
SUMMARY:Japanese vs. European View on Targeted Radionuclide Therapy
DESCRIPTION:This event is a collaboration between ESMIT and JSNM. The aim of the webinar is to compare the approach to targeted radionuclide therapy (TRT) in Japan and in Europe. The webinar will focus on the differences in the TRT environment in Japan vs. Europe\, including regulatory science and radiation protection regulation\, and more. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear Medicine Physicians \n\n\n\n \n\n\n\nFaculty\n\n\n\n\nTatsuya HigashiSpeaker \n\n\n\nWolfgang FendlerSpeaker \n\n\n\nConrad-Amadeus VoltinModerator \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/japanese-vs-european-view-on-targeted-radionuclide-therapy/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251204T080000
DTEND;TZID=Europe/Vienna:20251205T170000
DTSTAMP:20260407T113319
CREATED:20241017T084515Z
LAST-MODIFIED:20250624T123657Z
UID:1968-1764835200-1764954000@esmit.eanm.org
SUMMARY:Nuclear Medicine in Breast Cancer Based on FOCUS Meeting 6
DESCRIPTION:Breast cancer is the most relevant cancer in women worldwide. It is the second most frequently diagnosed cancer (after lung cancer) and the first leading cause of cancer-related death in women\, being the fourth globally regardless of gender. By 2040\, breast cancer is predicted to increase to over 3 million new cases and 1 million deaths per year. \n\n\n\nStaging patients with breast cancer is challenging due to its heterogeneous nature and presentation. Imaging is of utmost importance in all clinical settings\, particularly\, in staging\, assessing therapy response\, and detecting recurrence. Despite the well-stablished usefulness of radiologic modalities\, Nuclear Medicine has demonstrated an important role to play in breast cancer\, which has been increasingly supported by strong scientific evidence. Considering the patient’s long survival\, the benefits of assessing active tumour in an accurate way\, gain major importance in these patient’s care. \n\n\n\nThe recent equipment and radiopharmaceutical developments have opened the path to improve tumour characterization through several imaging possibilities. Currently\, the challenge is to use the correct combination of equipment and tracer at the right time. Furthermore\, homogenize imaging and clinical procedures is becoming even more important. \n\n\n\nDuring this course\, the highlights from the consensus reached during the multidisciplinary EANM Focus Meeting 6 about Nuclear Medicine diagnostics and therapeutics possibilities will be comprehensively presented and discussed in a close way between the faculty and attendees. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo understand breast cancer as a heterogeneous disease\, its characteristics and evolution;\n\n\n\nTo define the role of nuclear medicine techniques in different clinical settings (initial staging\, assessing therapy response\, and detecting recurrence);\n\n\n\nTo know the potential usefulness of PET tracers beyond FDG in each breast cancer subtype and use of the evolving PET technology & equipment;\n\n\n\nTo discuss future diagnostic and treatment approaches with radiopharmaceuticals.\n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear Medicine physicians\, Radiologists\, Medical Oncologists\, Radiation Oncologists\, Medical students\, Residents\, Nurses\, Nuclear Medicine technologists and Radiographers. \n\n\n\n \n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSofia VazSpeakerLisbon\, Portugal \n\n\n\n\n\nThiemo van NijnattenSpeakerMaastricht\, Netherlands \n\n\n\n\n\nPhilipp BackhausSpeakerMünster\, Germany \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/nuclear-medicine-in-breast-cancer-based-on-focus-meeting-6/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20251212T133000
DTEND;TZID=Europe/Vienna:20251212T143000
DTSTAMP:20260407T113319
CREATED:20241017T081824Z
LAST-MODIFIED:20251204T110136Z
UID:1944-1765546200-1765549800@esmit.eanm.org
SUMMARY:To AI or not to AI in Neurology: That is the Question
DESCRIPTION:This webinar will explore state-of-the-art AI approaches for advancing neuroimaging\, with a particular focus on quantitative PET. It will cover the entire imaging pipeline\, from preprocessing\, acquisition\, and tomographic reconstruction to quantification\, segmentation\, denoising\, and resolution enhancement\, demonstrating how modern AI can enable more reproducible and robust brain PET biomarkers. Through two expert presentations and practical case examples\, the webinar will showcase how AI-driven methodologies are reshaping neuroimaging research and supporting more accurate diagnosis and disease monitoring. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nLearn the principles behind AI-based quantitative PET methods\n\n\n\nUnderstand how AI can enhance each stage of the neuroimaging pipeline\, from preprocessing and reconstruction to segmentation\, denoising\, and resolution recovery.\n\n\n\nCritically assess when AI meaningfully improves neuroimaging workflows\n\n\n\nRecognize emerging opportunities and challenges in integrating AI tools into brain PET\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear physicians\, medical physicists\, imaging scientists and radiologists working in PET neuroimaging \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nPablo Aguilar FernándezModerator \n\n\n\n\n\nDimitris VisvikisSpeaker \n\n\n\n\n\nCharalampos TsoumpasSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/to-ai-or-not-to-ai-in-neurology-that-is-the-question/
CATEGORIES:AI & Quantification,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260130T000000
DTEND;TZID=Europe/Vienna:20280130T235959
DTSTAMP:20260407T113319
CREATED:20260113T132906Z
LAST-MODIFIED:20260223T101002Z
UID:3455-1769731200-1832889599@esmit.eanm.org
SUMMARY:Personalized Medicine in Prostate Cancer: From Diagnostic to Therapy
DESCRIPTION:This course has been accredited with 3 CME credits by the UEMS EACCME. \n\n\n\nRadiolabelled prostate-specific membrane antigen (PSMA) is increasingly used in imaging and treatment of prostate cancer. PSMA-directed radionuclide therapy is an efficacious new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and beyond. The online course will cover the spectrum of radiolabelled PSMA tracers\, techniques related to PSMA imaging\, from diagnosis to therapy\, with lectures\, interactive case discussions\, and relevant information for clinical practice. \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seat!Enter the eLearning platform  register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\nPSMA PET-CT imaging- science and practice:  \n\n\n\n\nTo provide an overview of clinical applications\, normal biodistribution\, variants\, pitfalls and artefacts in PSMA PET-CT \n\n\n\nTo learn how to report PSMA PET-CT scans in primary staging and recurrence\n\n\n\n\n \n\n\n\nRadionuclide PSMA therapy-science and practice (177Lu-PSMA therapies): \n\n\n\n\nTo gain knowledge on PSMA patients selection\, management of common clinical challenges in implementing and delivering of radionuclide therapies\, side effects and their management\n\n\n\nTo discuss current evidence and trends related to 177Lu-PSMA therapies \n\n\n\nTo learn about new or emerging targets and radioisotopes for Prostate cancer management\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nGeneral nuclear medicine specialists\, residents\, radiologists\, healthcare specialists who want to update their knowledge on molecular imaging and radionuclide therapy of prostate cancer including theranostics. \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nKarolien GoffinSpeaker \n\n\n\n\n\nWolfgang FendlerSpeaker
URL:https://esmit.eanm.org/event/personalized-medicine-in-prostate-cancer-from-diagnostic-to-therapy/
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260206T133000
DTEND;TZID=Europe/Vienna:20260206T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20260126T130413Z
UID:2840-1770384600-1770388200@esmit.eanm.org
SUMMARY:Innovations in Theranostics for Neuroblastoma
DESCRIPTION:This course provides a comprehensive update on instrumental and radiopharmaceutical innovations in the diagnosis and treatment of neuroblastoma. Participants will explore current and emerging imaging modalities\, with a comparative analysis of MIBG\, MFBF\, FDOPA\, and Gallium-based tracers\, highlighting their evolving roles in staging\, risk stratification\, and response assessment. \n\n\n\nThe course will address recent changes in clinical practice and the challenges these advancements pose for pediatric oncologists and nuclear medicine physicians\, emphasizing multidisciplinary decision-making. \n\n\n\nIn addition\, the program will review novel therapeutic strategies for refractory and relapsed neuroblastoma\, with a focus on radioligand therapy and its integration with immunotherapy approaches\, including CAR-T cell therapy. Through state-of-the-art updates and clinical perspectives\, the course aims to equip clinicians with practical insights for optimizing diagnostic accuracy and therapeutic outcomes in this complex pediatric malignancy. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\nDescribe recent instrumental and radiopharmaceutical innovations in the diagnosis and management of neuroblastoma.\n\n\n\nCompare the clinical indications\, advantages\, and limitations of MIBG\, MFBF\, FDOPA\, and Gallium-based imaging tracers in neuroblastoma.\n\n\n\nEvaluate how emerging imaging techniques are changing staging\, risk stratification\, and treatment response assessment in pediatric patients.\n\n\n\nIdentify current challenges and unmet needs faced by pediatric oncologists and nuclear medicine physicians in integrating new diagnostic tools into clinical practice.\n\n\n\nDiscuss the principles and clinical applications of radioligand therapy in refractory and relapsed neuroblastoma.\n\n\n\nAssess the potential role of combined treatment strategies\, including radioligand therapy with immunotherapy and CAR-T cell therapy\, in improving patient outcomes.\n\n\n\nApply multidisciplinary decision-making approaches to optimize personalized diagnostic and therapeutic strategies for children with neuroblastoma.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\nNuclear Medicine Physicians\n\n\n\n\n \n\n\n\n \n\n\n\nSuggested Reading\n\n\n\n \n\n\n\nSe Whee Sammy Park et al. Front Oncol 14:1408729. doi: 10.3389/fonc.2024.1408729 \, Lise Borgwardt et al\, The Journal of Nuclear Medicine (2024). DOI: 10.2967/jnumed.123.267256   \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nJulian RogaschSpeaker \n\n\n\n\n\nBart de KeizerSpeaker \n\n\n\n\n\nMarie LuporsiModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/innovations-in-theranostics-for-neuroblastoma/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260220T133000
DTEND;TZID=Europe/Vienna:20260220T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20260217T091153Z
UID:2843-1771594200-1771597800@esmit.eanm.org
SUMMARY:Beyond Single Modality: The Future of Cancer Staging with Hybrid Scanners
DESCRIPTION:This webinar will be on the future of cancer staging with hybrid imaging technologies. Participants will gain an overview of advanced PET/CT\, SPECT/CT\, and PET/MRI systems\, learning how hybrid imaging enhances diagnostic accuracy and supports more precise clinical decisions.The session will explore the practical challenges technologists face when working with these cutting-edge systems\, including image acquisition\, processing\, and interpretation\, while highlighting the technical skills needed for effective operation.We’ll also discuss educational gaps and training opportunities for radiographers and technologists\, presenting strategies such as hands-on workshops\, e-learning\, and mentorship to support professional development.By the end of this webinar\, attendees will have a clear understanding of the evolving role of technologists in hybrid oncological imaging and be inspired to embrace innovation\, lifelong learning\, and interdisciplinary collaboration. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nDescribe the most advanced hybrid imaging technologies used for oncological staging in nuclear medicine Understand the key features of PET/CT\, SPECT/CT\, and PET/MRI systems\n\n\n\nDistinguish the main advantages and limitations of hybrid modalities in clinical oncology\n\n\n\nUnderstand the added value of multimodality imaging compared with single-modality approaches Identify cases where hybrid imaging improves sensitivity\, specificity\, or diagnostic accuracy Recognize how functional-anatomical integration supports more precise clinical decisions\n\n\n\nAnalyze the main challenges faced by technologists in the acquisition\, processing\, and interpretation of hybrid imaging data Highlight practical issues (e.g.\, image registration\, calibration\, artifacts\, acquisition timing)Reflect on the technical skills required to operate hybrid systems effectively\n\n\n\nIdentify educational gaps and learning challenges encountered by radiographers/technologists when adopting new hybrid technologies Recognize organizational\, infrastructural\, and educational barriers (e.g.\, equipment availability\, supervision\, time constraints) Assess variations in training opportunities across European contexts\n\n\n\nPropose strategies and training programs for integrating hybrid skills into radiotherapy technician (RTM) programs\, fostering critical awareness of the evolving role of the technician in the context of hybrid oncology imaging.Suggest training models (advanced courses\, internships at centers of excellence\, e-learning\, hands-on workshops)Outline a roadmap for continuous development (on-the-job training\, certifications\, mentorships)\n\n\n\nPromote a proactive mindset toward technological innovation and self-development\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear medicine Technologists\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nOliver RamsaySpeaker \n\n\n\n\n\nNia HopsonSpeaker \n\n\n\n\n\nPaolo TurcoModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/beyond-single-modality-the-future-of-cancer-staging-with-hybrid-scanners/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260313T133000
DTEND;TZID=Europe/Vienna:20260313T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20260302T091708Z
UID:2845-1773408600-1773412200@esmit.eanm.org
SUMMARY:Radiobiological Aspects of PRRT
DESCRIPTION:This webinar will examine the fundamental differences between targeted radionuclide therapy (TRT) and conventional external beam radiotherapy (EBRT)\, integrating physical\, dosimetric\, and radiobiological perspectives relevant to clinical practice. Drawing on the EANM–ESTRO joint session\, the first part will outline how TRT’s systemic administration\, patient-specific pharmacokinetics\, protracted low dose-rate delivery\, and highly heterogeneous intratumoral distribution distinguish it from the controlled\, high dose-rate\, fractionated paradigm of EBRT. Emphasis will be placed on implications for treatment planning\, activity prescription\, imaging-based dosimetry\, and the limitations of directly translating EBRT concepts such as uniform dose coverage and standard fractionation models to TRT. \n\n\n\nThe second part will focus on how absorbed dose\, dose rate\, and spatial heterogeneity influence biological effectiveness and clinical outcomes in TRT. Key topics include sublethal damage repair during continuous irradiation\, challenges in applying conventional radiobiological models\, the impact of microscopic dose non-uniformity (especially for β- versus α-emitting therapies)\, and the relationship between local tumor control and systemic effects\, including immune modulation. The session aims to equip nuclear medicine physicians and medical physicists with a conceptual framework to interpret dosimetry results\, personalize treatments\, and critically evaluate emerging combination strategies as TRT evolves toward a quantitatively driven radiotherapy modality. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nDifferentiate the fundamental physical and clinical characteristics of TRT versus EBRT\, including source geometry\, temporal delivery\, dose-rate profiles\, and implications for treatment planning and prescription.\n\n\n\nExplain how pharmacokinetics and biodistribution govern absorbed dose in TRT\, and why activity administration alone is an insufficient surrogate for delivered dose and therapeutic effect.\n\n\n\nAssess the impact of dose rate and protracted irradiation on radiobiological response\, including sublethal damage repair\, limitations of conventional linear-quadratic modeling\, and consequences for tumor control and normal tissue toxicity.\n\n\n\nRecognize the clinical significance of spatial dose heterogeneity at organ\, tumor\, and cellular scales\, particularly differences between β-emitting and α-emitting radiopharmaceutical therapies.\n\n\n\nInterpret the relationship between dosimetry metrics and clinical outcomes\, including local control\, toxicity\, and potential systemic (immune-mediated) effects.\n\n\n\nApply these concepts to support patient-specific dosimetry\, treatment personalization\, and multidisciplinary decision-making in modern targeted radionuclide therapy practice.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nThis webinar is intended for nuclear medicine physicians and medical physicists involved in targeted radionuclide therapy\, including early-career professionals and practitioners seeking to deepen their understanding of the physical and radiobiological principles underpinning modern TRT practice.\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nDavid Sánchez-ArtuñedoSpeaker \n\n\n\n\n\nZachary MorrisSpeaker \n\n\n\n\n\nSamantha TerryModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/radiobiological-aspects-of-prrt/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260319T090000
DTEND;TZID=Europe/Vienna:20260320T123000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20260310T121614Z
UID:2807-1773910800-1774009800@esmit.eanm.org
SUMMARY:Dose-Effect Response to Targeted Radionuclide Therapy
DESCRIPTION:UEMS EACCME has granted the accreditation of 10.5 CME credits for this event. \n\n\n\nThis intensive 1\,5-day course bridges the gap between radiobiology\, dosimetry\, and clinical practice in targeted radionuclide therapy. Designed for early-career nuclear medicine physicians and medical physicists\, the programme explores dose-response relationships in the three most commonly used theranostic molecules: somatostatin-ligands for neuroendocrine tumours\, PSMA-inhibitors for prostate cancer\, and radioiodine for thyroid malignancies. \n\n\n\nThrough a balanced faculty of radiobiologists\, dosimetry experts\, and experienced nuclear medicine physicians\, participants will gain practical insights into the biological effects of radiation\, dosimetry calculation methodologies\, and their clinical implementation. The course emphasizes hands-on learning through joint case sessions\, interactive workshops\, and patient-specific treatment planning exercises. \n\n\n\nFormat: Lectures\, case discussions\, interactive workshops\, and panel sessions \n\n\n\n\n\n\n\nRegister nowThe registration is closed. \n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nAt the end of the two days\, participants of the course will be able to: \n\n\n\n\nExplain the fundamental radiobiological principles underlying dose-effect relationships in targeted radionuclide therapy and how they differ from external beam radiotherapy and brachytherapy.\n\n\n\nDescribe the complete workflow from imaging acquisition to dose calculation and apply core dosimetry concepts to clinical TRT scenarios.\n\n\n\nIntegrate dosimetry data into clinical decision-making for patient selection\, treatment planning\, and outcome prediction in targeted radionuclide therapy.\n\n\n\nCompare and contrast the clinical applications\, dose-response characteristics\, and dosimetric considerations for somatostatin-ligand therapy (neuroendocrine tumours)\, PSMA-inhibitor therapy (prostate cancer)\, and radioiodine therapy (thyroid disease).\n\n\n\nInterpret key clinical trial outcomes and evidence-based data related to dosimetry-guided TRT across the three major theranostic applications.\n\n\n\nDesign a patient-specific TRT treatment plan incorporating radiobiological principles\, dosimetric calculations\, and clinical considerations for organ protection and tumour targeting.\n\n\n\nIdentify the practical challenges and solutions for implementing dosimetry protocols in routine clinical nuclear medicine practice.\n\n\n\nCritically evaluate when and how personalized dosimetry can optimize therapeutic outcomes and minimize toxicity in individual patients.\n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nEarly-career nuclear medicine doctors and medical physicists \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJulie NonnekensSpeakerNetherlands \n\n\n\n\n\nLars Tore Gyland MikalsenSpeakerNorway \n\n\n\n\n\nFrancesco CiconeSpeakerItaly \n\n\n\n\nFrancesco GiammarilleSpeakerFrance \n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nNEW Department Package: If you send 5 participants from your department\, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you. \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/dose-effect-response-to-targeted-radionuclide-therapy/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260327T133000
DTEND;TZID=Europe/Vienna:20260327T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20260320T084326Z
UID:2847-1774618200-1774621800@esmit.eanm.org
SUMMARY:FDG PET/CT in Inflammation and Infection: from Theory to Clinical Practice!
DESCRIPTION:Imaging of infection and inflammation has been part of nuclear medicine since the 1970s. Over the past two decades\, the growing role of FDG PET/CT in diagnosing and monitoring the treatment of a wide variety of infectious and inflammatory diseases has been recognised. As a result\, this technique has recently been adopted in several clinical guidelines. This webinar provides clinical case-based evidence to assist nuclear medicine physicians in recommending\, performing and interpreting FDG PET/CT examinations in patients with infectious and inflammatory disorders. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nThe aim of this live webinar is to describe\, using illustrative clinical cases\, the role of FDG PET/CT in a variety of pathological conditions characterised by infection or inflammation\, with particular emphasis on strengths and limitations of FDG PET/CT.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear Medicine Physicians\, Residents\, Technologists\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nAyah NawwarSpeaker \n\n\n\n\n\nDomenico AlbanoSpeaker \n\n\n\n\n\nSøren HessSpeaker \n\n\n\n\n\nLucia LeccisottiModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fdg-pet-ct-in-inflammation-and-infection-from-theory-to-clinical-practice/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260410T133000
DTEND;TZID=Europe/Vienna:20260410T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20260403T090904Z
UID:2849-1775827800-1775831400@esmit.eanm.org
SUMMARY:Open your Heart on SPECT and PET Studies: Synergistic Information from the CT
DESCRIPTION:This webinar will cover synergetic information derived from the CT component in SPECT/CT and PET/CT examinations:  the first part we will focus on cardiac calcifications\, offering valuable insights into their detection and clinical relevance especially for myocardial perfusion scans. In the second half\, we will discuss incidental findings in the thorax\, helping clinicians recognize and interpret unexpected observations in SPECT/CT and PET/CT studies.  \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nThis webinar aims to equip attendees with practical knowledge that enhances diagnostic confidence\, facilitates interdisciplinary collaboration\, and improves patient outcomes in hybrid nuclear cardiology examination. Participants will gain a deeper understanding of: \n\n\n\n \n\n\n\n\nCardiac Calcifications with CT: Learn how to identify and assess cardiac calcifications using CT imaging\, recognize their clinical significance\, and understand their implications for cardiovascular disease risk stratification in PET/CT and SPECT/CT myocardial perfusion examinations\n\n\n\nIncidental Findings in the Thorax: Develop the ability to systematically evaluate incidental thoracic findings encountered in SPECT/CT and PET/CT studies\, differentiate between benign and pathological abnormalities\, and enhance decision-making for further clinical assessment.”info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear Medicine physicians\, Cardiologists with focus on cardiovascular imaging\, Radiologists\, Technologists\, Residents in Nuclear Medicine.\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nManar BadarnaSpeaker \n\n\n\n\n\nChristoph RyffelSpeaker \n\n\n\n\n\nFederico CaobelliModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/open-your-heart-on-spect-and-pet-studies-synergistic-information-from-the-ct/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260416T090000
DTEND;TZID=Europe/Vienna:20260417T123000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20260402T074125Z
UID:2823-1776330000-1776429000@esmit.eanm.org
SUMMARY:Nuclear Medicine in FUO/IUO: Why Are Children Different?
DESCRIPTION:This 1\,5-day course focuses on the growing field of integrated imaging in infectious and inflammatory diseases in children\, with an emphasis on hybrid imaging. \n\n\n\nThe panelists will introduce the participants to the specific aspects of paediatric patients in this growing field\, covering the most relevant topics of the clinical scenario and the technical options available in daily practice. \n\n\n\nThe participants will be confronted with frequent and less frequent disease pattern\, with ample opportunity for discussing clinical indications and image interpretation criteria. \n\n\n\nThe continuing interaction between paediatrician\, paediatric radiologist and nuclear medicine physician will show the practical implementation of an integrated approach\, with particular attention to radiation dose reduction and optimisation. \n\n\n\n\n\n\n\nRegistrationThe registration for this course is closed. Please get in touch with us at esmit@eanm.org if you still want to register. \n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nAfter the course the participants will be able to: \n\n\n\n\nDescribe the impact of new imaging modalities on the clincial workup of infectious and inflamamtory diseases in children\n\n\n\nIdentify the most relevant indications for hybrid imging in paediatric inflammatory and infectious diseases in children\n\n\n\nDescribe the different protocols for FDG imaging\, selecting the most indiated depending on age group and clinical setting\n\n\n\nDefine the correct workflow for integrated imaging in different clinical situations\, with particular regard to radiation dose optimisation\n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nPhysicians\, residents with special interest in paediatrics\, nuclear medicine\, radiology\, nurses and technicians of nuclear medicine or radiology unit. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nPietro ZucchettaSpeakerPadova\, Italy \n\n\n\n\n\nSandra TrapaniSpeakerFlorence\, Italy \n\n\n\n\n\nChiara GiraudoSpeakerPadova\, Italy \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nNEW Department Package: If you send 5 participants from your department\, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you. \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/nuclear-medicine-in-fuo-iuo-why-are-children-different/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260508T133000
DTEND;TZID=Europe/Vienna:20260508T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T090823Z
UID:2851-1778247000-1778250600@esmit.eanm.org
SUMMARY:Dosimetry in Clinical Trials
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/dosimetry-in-clinical-trials/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260529T133000
DTEND;TZID=Europe/Vienna:20260529T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T090948Z
UID:2854-1780061400-1780065000@esmit.eanm.org
SUMMARY:FAP and Stroma Imaging – Current and Future Applications
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fap-and-stroma-imaging-current-and-future-applications/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260611T090000
DTEND;TZID=Europe/Vienna:20260612T123000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251111T123035Z
UID:2826-1781168400-1781267400@esmit.eanm.org
SUMMARY:Bringing Therapy Radioisotopes into Clinical Radiopharmacy – Some Regulatory Aspects
DESCRIPTION:More information will come soon. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeThe programme will come soon. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nNEW Department Package: If you send 5 participants from your department\, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you. \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/bringing-therapy-radioisotopes-into-clinical-radiopharmacy-some-regulatory-aspects/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260619T133000
DTEND;TZID=Europe/Vienna:20260619T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251111T123803Z
UID:2856-1781875800-1781879400@esmit.eanm.org
SUMMARY:Navigating International Guidelines for the Management of Thyroid Cancer
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/navigating-international-guidelines-for-the-management-of-thyroid-cancer/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260703T133000
DTEND;TZID=Europe/Vienna:20260703T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T091236Z
UID:2859-1783085400-1783089000@esmit.eanm.org
SUMMARY:Auger Electron Emitters – Why Consider this Therapeutic Option?
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/auger-electron-emitters-why-consider-this-therapeutic-option/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260709T090000
DTEND;TZID=Europe/Vienna:20260710T123000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251106T104517Z
UID:2829-1783587600-1783686600@esmit.eanm.org
SUMMARY:PET in Multiple Myeloma: Evidences\, Applications and Perspectives
DESCRIPTION:More information will come soon. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeThe programme will come soon. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nNEW Department Package: If you send 5 participants from your department\, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you. \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/pet-in-multiple-myeloma-evidences-applications-and-perspectives/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260918T133000
DTEND;TZID=Europe/Vienna:20260918T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T091347Z
UID:2861-1789738200-1789741800@esmit.eanm.org
SUMMARY:Trustworthy AI and Human Oversight
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/trustworthy-ai-and-human-oversight/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260924T090000
DTEND;TZID=Europe/Vienna:20260925T123000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251111T123139Z
UID:2831-1790240400-1790339400@esmit.eanm.org
SUMMARY:Prostate Cancer Theranostics
DESCRIPTION:More information will come soon. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeThe programme will come soon. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nNEW Department Package: If you send 5 participants from your department\, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you. \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/prostate-cancer-theranostics-2/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261106T133000
DTEND;TZID=Europe/Vienna:20261106T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T091508Z
UID:2863-1793971800-1793975400@esmit.eanm.org
SUMMARY:With a Little Help of Artificial Intelligence for the Sake of Radiation Protection
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/with-a-little-help-of-artificial-intelligence-for-the-sake-of-radiation-protection/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261112T090000
DTEND;TZID=Europe/Vienna:20261113T123000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20250930T145535Z
UID:2833-1794474000-1794573000@esmit.eanm.org
SUMMARY:Biomarker Assessment for an Early Biological Diagnosis of Alzheimer's Disease
DESCRIPTION:More information will come soon. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeThe programme will come soon. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeCancellation Policy\n\nCourse Fee               FREE \n\n\n\nCourse includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nCourse does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/biomarker-assessment-for-an-early-biological-diagnosis-of-alzheimers-disease/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261127T133000
DTEND;TZID=Europe/Vienna:20261127T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251111T123905Z
UID:2865-1795786200-1795789800@esmit.eanm.org
SUMMARY:Ring Geometry SPECT/CT System
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/ring-geometry-spect-ct-system/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261203T090000
DTEND;TZID=Europe/Vienna:20261204T123000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251111T123336Z
UID:2835-1796288400-1796387400@esmit.eanm.org
SUMMARY:Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
DESCRIPTION:More information will come soon. \n\n\n\n\n\n\n\nRegister nowRegistration is now open\, save yourself a seat! Register now\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\nMore info will come soon. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nProgrammeThe programme will come soon. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nNEW Department Package: If you send 5 participants from your department\, you will get an additional 6th seat for free for this course. Please get in touch with the ESMIT office if this is of interest to you. \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/focus-on-benign-thyroid-disease-from-thyroid-nodule-to-hyperthyroidism-and-immune-disease-2/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261211T133000
DTEND;TZID=Europe/Vienna:20261211T143000
DTSTAMP:20260407T113319
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T091729Z
UID:2867-1796995800-1796999400@esmit.eanm.org
SUMMARY:Tips and Tricks on Imaging with New CZT SPECT Systems
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/tips-and-tricks-on-imaging-with-new-czt-spect-systems/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261231T000000
DTEND;TZID=Europe/Vienna:20261231T235900
DTSTAMP:20260407T113319
CREATED:20220901T101846Z
LAST-MODIFIED:20251016T123526Z
UID:1315-1798675200-1798761540@esmit.eanm.org
SUMMARY:Fundamentals of Research in Imaging and Theranostics – Part 1: Research Design
DESCRIPTION:UEMS EACCME has granted the accreditation of 4 CME credits for this event. \n\n\n\nThis online course is part of a long line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation\, as well as the design\, conductance and reporting of clinical research trials\, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications.  \n\n\n\nThese first two modules will represent part one of the course.  \n\n\n\nModule 1 will focus on the entire path from preclinical development to clinical translation of an imaging compound\, including the preclinical studies needed for the selection of a new candidate for clinical translation\, an overview of EU legislation on radiopharmaceuticals for diagnosis and therapy\, and the assessment of quality data and non-clinical data (pharmacology\, dosimetry and toxicology) for the IMP dossier.  \n\n\n\nModule 2 will be focused on the design of a proper trial. It will cover: the definition of objectives\, aims\, endpoints\, population\, statistical methods and examples of trial design schemes\, as well as dosimetry as far as healthy organs and in case of therapy tumour-absorbed dose. It will have a special focus on phase 0\, phase 1-2 trial\, early clinical phase 0-1-2 and investigator-driven clinical trial. \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n\n\nLearning Objectives:\n\n\n\nLearn about: \n\n\n\n\nPreclinical development and clinical translation of radiopharmaceuticals \n\n\n\nThe legislation on radiopharmaceuticals with a specific focus on the European scenario \n\n\n\nRequirements of IMPD for radiopharmaceuticals for imaging agents and theranostic/therapeutic molecules Interpretation of preclinical data to properly design and plan the clinical trial \n\n\n\nPhase 0\, phase 1 and phase 2 clinical trials with radiopharmaceuticals design \n\n\n\nPhase 0\, phase 1 and phase 2 clinical trials with radiopharmaceuticals conductance \n\n\n\nGMP\, GLP and GCP principles \n\n\n\nImportance of radioprotection and dosimetric estimates in early phase clinical trials\n\n\n\n\n\n\n\n\n\n\n\n\nTarget Audience:\n\n\n\n\nResearchers\, scientists\, nurses\, pharmacologists\, radiopharmacists\, residents and specialists in Nuclear Medicine/Oncology/Radiology who want to understand how clinical trials with radiopharmaceuticals in the early phase are unique and how the corresponding documents and trial design should be appropriately planned.\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the full event programme.  View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nPaola Anna ErbaUniversità degli Studi di Milano-Bicocca\, Italy \n\n\n\n\n\nSona BalogovaComenius University\, Bratislava\, Slovakia \n\n\n\n\n\nElisabeth von GuggenbergMedical University Innsbruck\, Austria \n\n\n\n\n\n\n\nMartina SolliniVita-Salute San Raffaele University\, Milan\, Italy \n\n\n\n\n\nLuigi AlojUniversity of Cambridge\, United Kingdom \n\n\n\n\n\nMeltem OcakIstanbul University\, Turkey \n\n\n\n\n\n\n\nPeter LavermanRadboud Universiteit Nijmegen\, The Netherlands \n\n\n\n\n\nJane SosabowskiQueen Mary\, University of London\, United Kingdom \n\n\n\n\n\nPetra KolencUniversity Medical Centre Ljubljana\, Slovenia \n\n\n\n\n\n\n\nClemens DecristoforoMedical University Innsbruck\, Austria \n\n\n\n\n\nPiotr GarnuszekPOLATOM\, Warsaw\, Poland \n\n\n\n\n\nRenata MikolajczakPOLATOM\, Warsaw\, Poland \n\n\n\n\n\n\n\nTheodosia MainaNCSR Demokritos\, Athens\, Greece \n\n\n\n\n\nMark KonijnenbergErasmus MC\, Rotterdam\, The Netherlands \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration Fee\n\nCourse Fee              Free \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fundamentals-of-research-in-imaging-and-theranostics-part-1-research-design/
LOCATION:Online
CATEGORIES:Research Methods,Self-paced Online Course
END:VEVENT
END:VCALENDAR